Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Skyward Specialty Insurance (SKWD) Cash & Equivalents (2021 - 2025)

Skyward Specialty Insurance (SKWD) has disclosed Cash & Equivalents for 4 consecutive years, with $168.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 38.6% to $168.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $168.5 million, a 38.6% increase, with the full-year FY2025 number at $168.5 million, up 38.6% from a year prior.
  • Cash & Equivalents was $168.5 million for Q4 2025 at Skyward Specialty Insurance, down from $2.1 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.1 billion in Q3 2025 to a low of $41.2 million in Q1 2023.
  • A 4-year average of $380.7 million and a median of $85.1 million in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: rose 8.12% in 2024, then skyrocketed 2095.24% in 2025.
  • Skyward Specialty Insurance's Cash & Equivalents stood at $45.4 million in 2022, then soared by 45.01% to $65.9 million in 2023, then skyrocketed by 84.55% to $121.6 million in 2024, then soared by 38.6% to $168.5 million in 2025.
  • Per Business Quant, the three most recent readings for SKWD's Cash & Equivalents are $168.5 million (Q4 2025), $2.1 billion (Q3 2025), and $136.6 million (Q2 2025).